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Background: Metabolic engineering has emerged as a practical alternative to conventional chemical conversion
particularly in biocommodity production processes. However, this approach is often hampered by as yet
unidentified inherent mechanisms of natural metabolism. One of the possible solutions for the elimination of the
negative effects of natural regulatory mechanisms on artificially engineered metabolic pathway is to construct an
in vitro pathway using a limited number of enzymes. Employment of thermostable enzymes as biocatalytic modules
for pathway construction enables the one-step preparation of catalytic units with excellent selectivity and
operational stability. Acetyl-CoA is a central precursor involved in the biosynthesis of various metabolites. In this
study, an in vitro pathway to convert pyruvate to acetyl-CoA was constructed and applied to N-acetylglutamate
production.
Results: A bypassed pyruvate decarboxylation pathway, through which pyruvate can be converted to acetyl-CoA,
was constructed by using a coupled enzyme system consisting of pyruvate decarboxylase from Acetobacter
pasteurianus and the CoA-acylating aldehyde dehydrogenase from Thermus thermophilus. To demonstrate the
applicability of the bypassed pathway for chemical production, a cofactor-balanced and CoA-recycling synthetic
pathway for N-acetylglutamate production was designed by coupling the bypassed pathway with the glutamate
dehydrogenase from T. thermophilus and N-acetylglutamate synthase from Thermotoga maritima. N-Acetylglutamate
could be produced from an equimolar mixture of pyruvate and α-ketoglutarate with a molar yield of 55% through
the synthetic pathway consisting of a mixture of four recombinant E. coli strains having either one of the
thermostable enzymes. The overall recycling number of CoA was calculated to be 27.
Conclusions: Assembly of thermostable enzymes enables the flexible design and construction of an in vitro
metabolic pathway specialized for chemical manufacture. We herein report the in vitro construction of a bypassed
pathway capable of an almost stoichiometric conversion of pyruvate to acetyl-CoA. This pathway is potentially
applicable not only to N-acetylglutamate production but also to the production of a wide range of acetyl-CoA-
derived metabolites.* Correspondence: honda@bio.eng.osaka-u.ac.jp
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The integration of diverse biocatalytic modules to ex-
pand the versatility of fermentation-based industries has
been widely employed for the production of biofuel,
pharmaceuticals, and other useful chemicals [1]. How-
ever, these “metabolic engineering” approaches often suf-
fer from flux imbalances because the naturally occurring
translational and transcriptional regulation mechanisms
fail to appropriately function in artificially engineered
cells [2,3]. One possible approach to overcome this limi-
tation is to construct an in vitro metabolic pathway in
which only a limited number of enzymes involved in the
pathway-of-interest are used as catalytic modules. In vitro
systems offer a number of potential advantages over the
conventional fermentation-based production processes
such as predictable production yield, operational flexibil-
ity, and scalability of the reaction [4,5]. However, the en-
zyme isolation generally requires laborious, costly, and
time-consuming procedures, and thus little attention has
been paid to the practical application of in vitro metabolic
engineering approaches. Recently, we reported a simple
approach to construct an in vitro artificial metabolic path-
way using thermostable biocatalytic modules [6,7]. The
basic procedure consists of the following four steps: 1) se-
lection of suitable thermostable enzymes; 2) expression of
the enzymes in mesophilic hosts (e.g. Escherichia coli);
3) preheating the cell suspension at high temperature; and
4) assembly of the catalytic modules at an experimentally
optimized ratio to achieve stoichiometric production. The
denaturation of indigenous enzymes at high temperatures
results in a one-step preparation of highly selective and
thermostable biocatalytic modules. The membrane struc-
ture of E. coli cells is partially or entirely disrupted at high
temperatures, and consequently, better accessibility be-
tween the enzymes and substrates can be achieved [8].
Acetyl-CoA is a key precursor for the biosynthesis of a
wide variety of industrially useful metabolites. In the
mevalonate pathway, acetyl-CoA is carboxylated and conju-
gated to form various isoprenoid and terpenoid compounds
that can be used as flavors, fragrances, and anticancer drugs
[9]. Condensation of two acetyl-CoA units leads to the
formation of acetoacetyl-CoA, which serves as a C4 back-
bone for polyhydroxyalkanoates and butanol biosynthesis
[10-12]. Acetyl-CoA production tends to be a rate-
limiting step of artificially engineered pathways to pro-
duce target compounds because acetyl-CoA serves a cen-
tral intermediate of a wide range of naturally occurring
metabolic pathways and thus is subjected to depletion
when it is routed into co-existing pathways [2].
In natural metabolism, acetyl-CoA is mainly generated
from pyruvate via three routes. Most aerobic microorgan-
isms use the large protein complex of pyruvate dehydro-
genase (PDH) to produce acetyl-CoA [13]. Alternatively,
pyruvate-ferredoxin oxidoreductase (PFOR) plays animportant role in the oxidative decarboxylation of pyru-
vate in some anaerobic bacteria and hyperthermophilic
achaea [14-16]. Pyruvate formate-lyase (PFL) is another
key enzyme involved in the carbohydrate metabolism of
anaerobic microorganisms [17,18]. However, none are
readily available in in vitro production systems. PDH is
one of the largest protein complexes and consists of
multiple copies of three or four subunits [19]. For ex-
ample, the PDH of E. coli consists of a central cubic
core composed of 24 molecules of dihydrolipoamide
acetyltransferase (E2), onto which up to 24 copies of pyru-
vate dehydrogenase (E1) and 12 copies of dihydrolipoamide
dehydrogenase (E3) are assembled [19]. To our knowledge,
there have been no reports on the functional expression of
the complete form of PDH in heterologous hosts probably
owing to their highly complex nature. PFORs require
specific redox partner proteins, namely ferredoxin and
ferredoxin reductase, to exert their catalytic abilities.
In in vitro systems, the enzymes and the partner pro-
teins freely diffuse in the reaction mixture, resulting in less
frequent interactions between them. In addition, the poor
oxygen tolerance of PFOR results in operational limita-
tions for its in vitro use. Similarly, PFL is highly sensitive
to oxygen stress [20].
To overcome these limitations, in this study, we
constructed an in vitro bypassed pathway capable of
converting pyruvate to acetyl-CoA using an enzyme
couple of thermostable pyruvate decarboxylase and CoA-
acylating aldehyde dehydrogenase. Owing to the ab-
sence of a co-existing pathway, an almost stoichiometric
production of acetyl-CoA could be achieved through the
in vitro pathway. Furthermore, the performance of this
pathway was assessed by integration to an artificial path-
way for the production of N-acetylglutamate (NAG), which
can be used as an ingredient in the cosmetic industry as an
anti-odor compound and skin moisturizer [21,22].
Results
Construction of the bypassed pyruvate decarboxylation
pathway
A bypassed pyruvate decarboxylation pathway was designed
by using an enzyme couple of pyruvate decarboxylase and
CoA-acylating aldehyde dehydrogenase (Figure 1). Among
microbial pyruvate decarboxylases, those from mesophilic
bacteria, including Zymomonas mobilis [23] and Acetobac-
ter pasteurianus [24], are biochemically well characterized.
Although BLAST searches of the genomic sequences of
(hyper)thermophiles gave no hits when the amino acid se-
quences of these enzymes were used as queries, the pyru-
vate decarboxylase from A. pasteurianus (ApPDC) has
been reported to have a relatively high thermal stability
with a half-life of 2 h at 60°C [24,25]. The CoA-acylating
aldehyde dehydrogenase was obtained from those involved






































Figure 1 Schematic illustration of the designed pathway for NAG production. Abbreviations used: ApPDC, pyruvate decarboxylase from
Acetobacter pasteurianus; TtADDH, CoA-acylating aldehyde dehydrogenase from Thermus thermophilus; TtGDH, glutamate dehydrogenase from



















Figure 2 Effect of CoA concentrations on the reaction
specificity of TtADDH. The reaction was performed at 50°C in the
mixture composed of 50 mM HEPES-NaOH (pH 7.0), 1 mM NAD+,
1 mM acetaldehyde, approximately 0.16 U ml-1 TtADDH, and the
indicated concentrations of CoA. After the preincubation for 1 min
at 50°C, the reaction was initiated by the addition of acetaldehyde.
After the incubation at 50°C for 1 min, the reaction was quenched
by adding an equal volume of ice-cold 0.5 N HCl in methanol. The
mixture was analyzed by HPLC to quantify acetate (green bar) and
acetyl-CoA (yellow bar).
Krutsakorn et al. Microbial Cell Factories 2013, 12:91 Page 3 of 9
http://www.microbialcellfactories.com/content/12/1/91HB8 [26] and designated as TtADDH. We found that
TtADDH could catalyze the oxidation of acetaldehyde in
both CoA-dependent (acetyl-CoA-forming) and CoA-
independent (acetate-forming) manners (Figure 2). In-
creased CoA concentration (up to 0.5 mM) led to the shift
in the reaction specificity of the enzyme to the acetyl-
CoA-forming direction (Figure 2). On the other hand,
CoA concentration higher than 0.5 mM caused a marked
inhibition of the enzyme activity. The CoA concentration
of 0.2 mM was used in further studies since no significant
difference was observed in the reaction specificity and the
activity of TtADDH at CoA concentrations of 0.2 and
0.5 mM.
ApPDC could retain more than 60% of its activity after
incubation at 50°C for 4 h, whereas no apparent de-
crease was observed in the activity of TtADDH at 50°C
(Figure 3a and b). Conversely, the activities of both en-
zymes steeply declined at an incubation temperature of
60°C or higher. Thus, a reaction temperature of 50°C
was used for further studies.
When the heat-treated cells having ApPDC and
TtADDH were incubated with an equimolar mixture
of pyruvate, NAD+, and CoA (2 mM each) at 50°C,
acetyl-CoA could be produced with a molar yield of
65% (Figure 4). A relatively slow production rate ob-
served in the initial 2 h is probably attributed to the
inhibitory effect of the high initial concentration of
CoA on TtADDH.Design of the NAG production pathway
The bypassed pyruvate decarboxylation pathway was in-
tegrated into a newly designed synthetic pathway for
NAG production to evaluate its applicability to chemical

































































Figure 3 Thermal stability of ApPDC (a), TtADDH (b), TtGDH (c), and TmNAGS (d). Crude lysates of the recombinant E. coli were preheated
at 70°C for 30 min; an incubation temperature of 60°C was employed for preheating the lysate having ApPDC. After the removal of denatured
proteins by centrifugation, the enzyme solutions were incubated at 50°C (blue diamond), 60°C (yellow square), and 70°C (green triangle) for the
indicated time periods. Residual enzyme activity was determined using the standard assay conditions.
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to glutamate catalyzed by N-acetylglutamate synthase
(NAGS). CoA molecules released by the acetylation of
glutamate can be recycled for the synthesis of acetyl-CoA



















Figure 4 Acetyl-CoA production through the bypassed pyruvate
decarboxylation pathway. Heat-treated cells of recombinant
E. coli having ApPDC and TtADDH (approximately 8 and 4 mg ml-1,
respectively) were incubated at 50°C with 2 mM each of pyruvate,
NAD+, and CoA. Acetyl-CoA (green circle), CoA (yellow square) and
acetate (blue diamond) concentrations were quantified by HPLC.thermostable NAGS, which is involved in the arginine bio-
synthesis pathway of Thermotoga maritima, is well char-
acterized [27], therefore, the NAGS from T. maritima was
selected as the module to construct the pathway and des-
ignated TmNAGS.
Unlike natural metabolic pathways, which are equipped
with a complete enzyme apparatus for the de novo synthe-
sis of cofactors, indigenous regeneration of redox cofac-
tors is necessary to facilitate the economic feasibility of
in vitro production processes [4,6]. To achieve balanced
NAD+/NADH consumption and regeneration, the glu-
tamate dehydrogenase of T. thermophilus (TtGDH) was
integrated into the NAG production pathway. The en-
zyme can use α-ketoglutarate, an inexpensive material, as
a cosubstrate for the re-oxidation of NADH and to pro-
duce glutamate, which can be directly used as the sub-
strate for TmNAGS. Thermal stability analysis of
TmNAGS and TtGDH demonstrated that they can be
used at 50°C for at least 4 h without a significant loss of
their activities (Figure 3c and d).
NAG production
Activities of ApPDC, TtADDH, TtGDH, and TmNAGS
were assessed under the standard assay conditions at a
substrate concentration of 0.2 mM. One unit (U) of either
enzyme was defined as the amount capable of product for-
mation at a rate of 1.0 μmol min-1. Enzyme activities were
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binant E. coli cells (Table 1). The pH profiles of the en-
zymes revealed that the total protein concentration in the
mixture of the crude extracts containing 0.04 U ml-1 of
each enzyme can be minimized at pH 7.0.
The flux through the bypassed pyruvate decarboxyl-
ation pathway could be determined by incubating an
enzyme mixture of ApPDC and TtADDH with 0.2 mM
each of pyruvate, CoA, and NAD+, and monitoring the
concomitant production rate of NADH at 340 nm. When
equal units (0.04 U ml-1) of the enzymes were used, the
initial NADH production rate was lower than the
expected value of 0.04 μmol min-1 ml-1. In the constructed
pathway, the actual concentration of acetaldehyde, which
is generated by ApPDC and then used as the substrate for
TtADDH, was kept at a lower level than those used in the
standard assay, and thus TtADDH failed to catalyze the
reaction at the expected rate. We increased the TtADDH
concentration in the reaction mixture in a stepwise man-
ner, and found that the expected NADH production rate
of 0.04 μmol min-1 ml-1 could be achieved by using 0.09 U
ml-1 of TtADDH.
The direct production of NAG from pyruvate and
α-ketoglutarate was performed by using a mixture of heat-
treated recombinant cells having the experimentally deter-
mined amounts of enzymes to achieve a production rate
of 0.04 μmol ml-1 min-1 (i.e. 0.04 U ml-1 each of ApPDC,
TtGDH, and TmNAGS, and 0.09 U ml-1 of TtADDH).
The reaction was performed in a mixture containing
0.2 mM each of pyruvate, α-ketoglutarate, L-glutamate,
and CoA. A mixture of pyruvate, α-ketoglutarate, and
NH4Cl was continuously supplied into the reaction mix-
ture at a rate of 0.04 μmol ml-1 min-1 to keep a constant
flux. However, NAG production stopped after 2 h despite
the sufficient thermal stabilities of the enzymes (Figure 5a).
The time profile analysis of the pool sizes of the interme-
diates and cofactors revealed the concentrations of the
redox cofactors, NAD+ and NADH, decreased time de-
pendently while those of acetaldehyde and α-ketoglutarate
remarkably increased (Figure 5b). These facts implied that
the thermal decomposition of the redox cofactors led toTable 1 pH profile of enzyme activity
Buffer pH Specific activity (U mg-1 total p
ApPDC TtADDH TtGDH
MES 6.0 0.046 0.067 0.164
MES 6.5 0.066 0.146 0.255
HEPES 7.0 0.078 0.137 0.291
HEPES 7.5 0.058 0.197 0.184
Bicine 8.0 0.046 0.246 0.074
Bicine 8.5 0.025 0.450 0.026
aSpecific activities are expressed as those from the crude extract of recombinant E.
bTotal protein concentrations in the mixture of crude extracts containing 0.04 U ofthe decrease in the catalytic performance of NAD(H)-
dependent enzymes, TtADDH and TtGDH. Moreover,
owing to its highly volatile nature, acetaldehyde accumula-
tion likely led to the loss in the NAG production yield
through the constructed pathway. On the basis of these
observations, a NAG production assay was conducted
with a continuous feeding of NADH at a rate identical to
that of the thermal decomposition (3.3 nmol ml-1 min-1).
Consequently, 5.3 mM of NAG could be produced with a
molar yield of 55% after a 4-h reaction. The total recycling
number of CoA was calculated to be 27. The time profile
of intermediates confirmed that the accumulation of α-
ketoglutarate and acetaldehyde could be mitigated by the
addition of NADH (Figure 5c).
Discussion
Acetyl-CoA is an essential intermediate for the produc-
tion of a variety of metabolites; therefore intensive stud-
ies have been conducted to increase the intracellular
level of acetyl-CoA in artificially engineered microorgan-
isms. Atsumi et al. reported that the increases in the intra-
cellular pool size of acetyl-CoA, which can be achieved by
deleting the gene sets of ldhA, adhE, and frdBC of E. coli,
leads to a two-fold increase in 1-butanol production by
the engineered cells [2]. Shiba et al. have engineered a
pyruvate dehydrogenase bypass pathway in Saccharomyces
cerevisiae to increase intracellular acetyl-CoA and to im-
prove the production level of amorphadiene, a sesquiter-
pene precursor for the biosynthesis of the anti-malarial
drug artemisinin [28]. Furthermore, Chen et al. have
developed an engineered yeast platform for improved
acetyl-CoA production and demonstrated its application
for α-santalene production [12].
Previously, we reported a simple approach to construct
an in vitro artificial metabolic pathway using thermo-
stable biocatalytic modules [6,7]. This approach is, in
principle, applicable to any thermostable enzyme as long
as it can be functionally expressed in a mesophilic host,
and thus is potentially applicable to the biocatalytic
manufacture of a wide range of useful compounds. By
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Figure 5 Time course analysis of NAG production. (a) Time profiles of NAG production. Reaction was performed with (yellow square) and
without (green circle) NADH feeding at a rate of 3.3 μmol l-1 min-1. (b, and c) Time profiles of the cofactors and intermediates during NAG





























Figure 6 Effect of NAG concentration on TtGDH. The enzyme
activity was determined under the standard assay conditions at the
indicated concentrations of NAG.
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the direct conversion of glucose to lactate [6] and malate
[7]. The construction of an in vitro pyruvate decarboxyl-
ation pathway to form acetyl-CoA was one of the key
challenges remaining to expand the applicability of this
system.
In this study, we constructed an in vitro bypassed
pathway for pyruvate decarboxylation by employing an
enzyme couple of ApPDC and TtADDH. The bypassed
pathway was integrated into the newly designed syn-
thetic pathway for NAG production, in which consump-
tion and regeneration rates of both NAD(H) and CoA
were essentially balanced. The highly traceable nature of
the in vitro synthetic pathway enabled us to quantify the
intermediate pool sizes without using special equipment
and to identify the rate-limiting of the synthetic pathway.
The time-course analysis of the intermediates in the
NAG-producing pathway indicated that the decrease in
the catalytic ability of TtGDH and TtADDH caused by
the thermal decomposition of NAD(H) was the bottle-
neck. In fact, by continuously supplying NADH to the
reaction mixture, 5.4 mM NAG could be produced with
a molar yield of 55% and a CoA-recycling number of
27 could be achieved. The operational stability of the
in vitro production system would be improved by the
screening and employment of a thermostable glutamate
dehydrogenase with lower Km for NAD(H). However, the
intermediate analysis indicated that accumulation of α-
ketoglutarate was still not insignificant even when NADH
was supplied (Figure 5c). This can be explained by the in-
hibitory effect of NAG on TtGDH (Figure 6). Although
in vitro synthetic pathways are independent of transcrip-
tional and translational regulatory mechanisms of living
cells, allosteric regulation cannot be necessarily elimi-
nated. Protein engineering approaches or the substitutionwith another enzyme module that is less sensitive to
allosteric effects would be a straightforward way to elimin-
ate the effect of allosteric inhibition. In fact, we previously
demonstrated that the inhibitory effect of NAD+ on lac-
tate production through the chimeric glycolytic pathway
can be eliminated by changing the NAD+-sensitive lactate
dehydrogenase to malate/lactate dehydrogenase [6]. Use
of a NAG-insensitive thermophilic glutamate dehydro-
genase would be needed to achieve a higher titer of NAG
production through the synthetic pathway.
Another possible approach to mitigate the effect of
product inhibition is the employment of a continuous
product recovery system. Recently, we reported that the
pretreatment of recombinant E. coli cells having a
thermophilic fumarase with a low concentration glutar-
aldehyde (~0.15 vol%) can consolidate the membrane
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age of the enzyme [8]. The glutaraldehyde-treated cells
can be used at 70°C for more than 10 h in a continuous
reactor equipped with a cell-separation membrane filter.
In the conversional fermentation-based processes, the
culture broth contains a number of impurities including
residual sugars, nutrients, and other organic materials,
apart from cell mass. By contrast, in in vitro production
systems, the reaction can be performed in a simple buf-
fer solution, and thus the product separation step can be
considerably simplified. Development and integration
of an on-line product separation system would be a
key challenge to eliminate product inhibition and to
achieve the long-term operation of the in vitro pro-
duction system.
Conclusions
We designed and constructed an in vitro pyruvate de-
carboxylation pathway capable of converting pyruvate
to acetyl-CoA using an enzyme couple of ApPDC and
TtADDH. To demonstrate the applicability of the
bypassed pathway to chemical production, the path-
way was coupled with TtGDH and TmNAGS to con-
struct a cofactor-balanced and CoA-recycling pathway
for NAG production. The highly traceable nature of
the in vitro pathway enabled us to readily identify the
rate-limiting enzyme. Consequently, 5.4 mM of NAG
could be produced through the pathway with a molar
yield of 55% and a CoA-recycling number of 27. The
bypassed pathway constructed in this study would be widely
applicable to the production of other acetyl-CoA-derived
chemicals including n-butanol, polyhydroxyalkanoates,
and isoprenoids.
Materials and methods
Bacterial strain and plasmid
The expression plasmids encoding TtADDH (Genebank ac-
cession number, YP_145486.1) and TtGDH (YP_144842.1)
were obtained from the RIKEN T. thermophilus HB8
expression plasmid set [26]. The gene coding for
ApPDC (YP_005499956.1) was amplified by PCR from
the chromosomal DNA of A. pasteurianus using the
following primers: 5′-AACATATGACCTATACTGT
TGGCAT-3′ (the NdeI restriction site is shown in
italics) and 5′-TTCTCGAGTCAGGCCAGAGTCGTC
TTGC-3′ (the XhoI restriction site is shown in
italics). The amplified DNA was digested with NdeI
and XhoI and inserted into the corresponding restric-
tion sites of pET21a (Novagen, Madison, WI, USA).
Similarly, the gene encoding TmNAGS (NP_229580.1)
was amplified from the chromosomal DNA of T.
maritima using a primer pair of 5′-AACATATGT
TCACTCCCAGGGGTTT-3′ (the NdeI restriction site
is shown italics) and 5′-TTGAATTCTCATGTTCTGTACCTCCCGT-3′ (the EcoRI restriction site is shown
italics), and then introduced into pET21a. The expression
vectors were separately introduced in E. coli Rosetta2
(DE3) (Novagen). Recombinant cells were cultivated aer-
obically at 37°C in Luria-Bertani (LB) media supplemented
with 50 μg ml-1 ampicillin and 30 μg ml-1 chlorampheni-
col. Isopropyl-β-D-1-thiogalactopyranoside was added
to the culture at a final concentration of 0.2 mM in
the late-log phase. The cells were harvested by centrifuga-
tion and washed once with 50 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES)-NaOH buffer
(pH 7.0).
Enzyme preparation
Recombinant cells were suspended in an appropriate
volume of 50 mM HEPES-NaOH (pH 7.0) and disrupted
using an UD-201 ultrasonicator (Kubota, Osaka, Japan)
at 80 W for 2 min. Cell debris were removed by centrifu-
gation at 12,000 × g at 4°C for 10 min. Protein concentra-
tion in the crude lysates was measured using a Bio-Rad
assay system (Bio-Rad, Hercules, CA, USA) with bovine
serum albumin as the standard. The resulting crude ly-
sates were incubated at 70°C for 30 min to inactivate the
indigenous enzymes. An incubation temperature of 60°C
was employed for the heat treatment of the lysate with
ApPDC. The heat-treated lysates were centrifuged again
to remove the denatured protein and then the superna-
tants were used as enzyme solutions.
Enzyme assay
All assays were performed at 50°C in 50 mM HEPES-
NaOH (pH 7.0) supplemented with 100 mM KCl and
10 mM MgCl2 unless otherwise stated. Activities of
ApPDC, TtADDH, and TtGDH were spectrophotomet-
rically determined by monitoring the consumption or
formation rate of NADH at 340 nm. TtADDH was
assayed in the buffer containing 0.2 mM NAD+, 0.2 mM
CoA, and an appropriate amount of the enzyme. After
the preincubation at 50°C for 2 min, the reaction was
started by the addition of acetaldehyde at a final concen-
tration of 0.2 mM, and the reduction of NAD+ was mon-
itored at 340 nm. The activity of TtGDH was assessed in
a similar manner by monitoring the oxidation of NADH
upon the reduction of 0.2 mM α-ketoglutarate. ApPDC
activity was assessed by coupling with TtADDH. After
the preincubation of the enzymes at 50°C in the buffer
containing 0.2 mM NAD+, 0.2 mM CoA, and an excess
amount of TtADDH, the reaction was initiated by the
addition of 0.2 mM pyruvate and monitored at 340 nm.
TmNAGS activity was assessed by determining the
NAG production rate by high-performance liquid chro-
matography (HPLC). The appropriate amount of enzyme
solution was incubated at 50°C in the buffer containing
0.2 mM each of L-glutamate and acetyl-CoA. The
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ume of ice-cold methanol. HPLC analysis was performed
as described below. One unit (U) of the enzyme was de-
fined as the amount capable of product formation at a
rate of 1 μmol min-1.
NAG production
The basal reaction mixture was composed of 100 mM
KCl, 10 mM MgCl2, 0.2 mM CoA, 0.2 mM NAD
+,
0.2 mM NADH, and 50 mM HEPES-NaOH (pH 7.0).
Recombinant cells were suspended in 50 mM HEPES-
NaOH (pH 7.0) and heated at 70°C for 30 min, although
an incubation temperature of 60°C was employed for
the heat-treatment of E. coli having ApPDC. The heat-
treated suspensions of E. coli having ApPDC, TtADDH,
TtGDH, and TmNAGS were added into the reaction mix-
ture at final concentrations of 16, 7, 50, and 10 mg (wet
weight cells) ml-1, respectively. The mixture (8 ml) was
placed in a 10-ml rubber-capped cylindrical vessel and
stirred in a water bath kept at 50°C. The reaction was initi-
ated by adding the indicated concentrations of substrates
and the intermediates. The feeding of a substrate solution
consisting of 100 mM each of α-ketoglutarate, pyruvate,
and NH4Cl was started using a LC-20 AD solvent delivery
unit (Shimadzu, Kyoto, Japan). The feeding rate was kept
at 3.2 μl min-1 (= 0.04 μmol ml-1 min-1). Simultaneously,
0.2 mM pyruvate, 0.2 mM acetyl-CoA, 0.2 mM α-
ketoglutarate, 0.2 mM L-glutamate, and 100 mM NH4Cl
were added to the reaction mixture to maintain the con-
stant pool sizes. The reaction was quenched at timed in-
tervals by the addition of an equal volume of pre-cooled
methanol and analyzed to determine the product and
intermediates.
Analytical methods
Acetate, α-ketoglutarate, pyruvate, and NAG were deter-
mined by HPLC on two ion exclusion columns connected
in tandem as described previously [6]. CoA and acetyl-
CoA were quantified by HPLC using a Cosmosil 5C18-
ARII column (4.6 × 250 mm, Nacalai Tesque, Kyoto,
Japan). The column was eluted with 0.1% (v/v) orthophos-
phate solution for the initial 2 min and then with a linear
gradient of methanol (0–30 vol%) for 10 min. The
column was maintained at 40°C and the flow rate of
1.0 ml min-1 was employed for the elution. The eluent was
analyzed with a SPD-20AV UV-VIS detector (Shimadzu)
at 254 nm. Aldehydes were fluorescence-labeled with 1,3-
cyclohexanedione as described elsewhere [29] and deter-
mined using HPLC on the same column. The column was
eluted at 40°C using 30% (v/v) acetonitrile at a flow rate of
0.5 ml min-1. The eluent was analyzed with an RF10A
fluorometric detector (Shimadzu) at excitation and emis-
sion wavelengths of 366 and 440 nm, respectively. NAD
(H) and glutamate were quantified using commercial kitsas described in the instructions provided by the manufac-
turers (Biovision, Mountain View, CA, USA and Cosmo
Bio, Tokyo, Japan, respectively).
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